Bucking the Trend: 3 Stocks That Zoomed While the Market Crashed

Market Overview - Last week's market turmoil was not indicative of a broad-based collapse, with the S&P 500 closing largely unchanged despite fears of a U.S. recession and volatility in AI-powered tech stocks [1] - Some stocks demonstrated resilience, posting double-digit gains during the market downturn and continuing to show strong performance afterward [2] Company Performances Latham Group (SWIM) - Latham Group's stock initially fell 10% but rebounded to a 64% gain after reporting better-than-expected second-quarter profits [4][5] - The company reported a 10% decline in sales to $160 million but improved profitability due to cost structure enhancements and production efficiencies [5] - Analysts expect an 8% sales decline for the full year to $520 million, with profits projected to drop from 21 cents to 3 cents per share before recovering to 11 cents the following year [6] Lumen Technologies (LUMN) - Lumen Technologies' stock surged 150% before retracting some gains, driven by its involvement in AI infrastructure [8] - The company has signed over $5 billion in partnership deals related to AI and anticipates additional opportunities worth over $7 billion [10] - Despite the stock's rise, it remains undervalued, with potential price targets suggesting a 40% upside from current levels [11] TenX Keane Acquisition (TENK) - TenX Keane Acquisition experienced a significant stock increase of 275% following shareholder approval of its merger with Citius Pharmaceuticals [12] - The merger is expected to close soon, with the combined entity rebranded as Citius Oncology [12] - Citius recently received FDA approval for its Lymphir therapy, presenting a market opportunity valued between $300 million and $400 million, with analysts projecting a 470% upside based on current trading prices [14]